|
Year
|
Position
|
|
Since 2024
|
Apl. Professor, UMG
|
|
Since 2023
|
Head, Colorectal Cancer Center, UMG
|
|
Since 2023
|
Coordinator, Esophageal Cancer Center, UMG
|
|
Since 2023
|
Coordinator, Gastric Cancer Center, UMG
|
|
Since 2023
|
Head, Tumorboard for Gastrointestinal Cancer, UMG
|
|
2018
|
Board Certification in Specialized Visceral Surgery
|
|
Since 2017
|
“Geschäftsführender Oberarzt”; Department of General, Visceral and Pediatric Surgery; UMG
|
|
Since 2016
|
Coordinator, Colorectal Cancer Center; UMG
|
|
Since 2014
|
Senior Physician / Attending Surgeon
|
|
2014
|
Habilitation (venia legend: Surgery)
|
|
2012
|
Board Certification in Visceral Surgery
|
|
2009-2011
|
Co-Principal investigator: “Distribution, characteristics and therapeutic relevance of CD133 expressing tumor (stem) cell populations in rectal carcinoma models“, DFG
|
|
Since 2008
|
Department of General, Visceral and Pediatric Surgery; UMG
|
|
2007-2008
|
Postdoctoral Fellowship: Laboratory of Dr. Thomas Ried, Section of Cancer Genomics, National Cancer Institute, National Institutes of Health (Bethesda, Maryland)
|
|
2004
|
Full “Approbation” as Physician, Georg-August-University Göttingen
|
|
2004
|
Dr. med. (“magna cum laude”), Georg-August-University Göttingen (Supervisor Prof. Dr. Heinz Becker, Mentor Dr. Michael Ghadimi)
|
|
2002-2003
|
Laboratory of Dr. Thomas Ried, Section of Cancer Genomics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
|
|
1997-2004
|
Studies of Human Medicine; Georg-August-University Göttingen and Johns Hopkins University Baltimore, Maryland, USA
|
